Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSV

This publication has 22 references indexed in Scilit:

• Vaccination of Cotton Rats with a Chimeric FG Glycoprotein of Human Respiratory Syncytial Virus Induces Minimal Pulmonary Pathology on Challenge
  The Journal of Infectious Diseases, 1991
• Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization
  Vaccine, 1990
• Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease
  Vaccine, 1989
• Protection of Cotton Rats against Human Respiratory Syncytial Virus by Vaccination with a Novel Chimeric FG Glycoprotein
  Journal of General Virology, 1989
• Characterization of a Novel Human Respiratory Syncytial Virus Chimeric FG Glycoprotein Expressed Using a Baculovirus Vector
  Journal of General Virology, 1989
• Purification and Characterization of the Respiratory Syncytial Virus Fusion Protein
  Journal of General Virology, 1985
• Revaccination of previous recipients of killed measles vaccine: Clinical and immunologic studies
  The Journal of Pediatrics, 1978
• Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants
  The Journal of Pediatrics, 1976
• Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines
  JAMA, 1967
• Skin tests with measles and poliomyelitis vaccines in recipients of inactivated measles virus vaccine. Delayed dermal hypersensitivity
  JAMA, 1967